<?xml version="1.0" encoding="UTF-8"?>
<ref id="r106">
 <label>106</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Kraus</surname>
   <given-names>WE</given-names>
  </string-name>, 
  <string-name>
   <surname>Bhapkar</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Huffman</surname>
   <given-names>KM</given-names>
  </string-name>, 
  <string-name>
   <surname>Pieper</surname>
   <given-names>CF</given-names>
  </string-name>, 
  <string-name>
   <surname>Krupa Das</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Redman</surname>
   <given-names>LM</given-names>
  </string-name>, 
  <string-name>
   <surname>Villareal</surname>
   <given-names>DT</given-names>
  </string-name>, 
  <string-name>
   <surname>Rochon</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Roberts</surname>
   <given-names>SB</given-names>
  </string-name>, 
  <string-name>
   <surname>Ravussin</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Holloszy</surname>
   <given-names>JO</given-names>
  </string-name>, 
  <string-name>
   <surname>Fontana</surname>
   <given-names>L</given-names>
  </string-name>, and 
  <collab>CALERIE Investigators</collab>. 
  <article-title>2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.</article-title>
  <source>Lancet Diabetes Endocrinol</source>. 
  <year>2019</year>; 
  <volume>7</volume>:
  <fpage>673</fpage>â€“
  <lpage>83</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2213-8587(19)30151-2</pub-id>
  <?supplied-pmid 31303390?>
  <pub-id pub-id-type="pmid">31303390</pub-id>
 </mixed-citation>
</ref>
